Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1
- 1 January 2005
- journal article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 94 (10) , 780-786
- https://doi.org/10.1160/th05-02-0082
Abstract
Schattauer GmbH - Verlag für Medizin und Naturwissenschaften ist ein renommierter Herausgeber von Fachbüchern, -zeitschriften und -software. Besuchen Sie unser Internetangebot mit Onlinezugang zu unseren ZeitschriftenartikelnKeywords
Funding Information
- DFG (01-100/3)
This publication has 23 references indexed in Scilit:
- Engineering of a Recombinant Vitamin K-dependent γ-Carboxylation System with Enhanced γ-Carboxyglutamic Acid Forming CapacityJournal of Biological Chemistry, 2005
- A single in vivo-selected point mutation in the active center ofToxoplasma gondiiferredoxin-NADP+reductase leads to an inactive enzyme with greatly enhanced affinity for ferredoxinFEBS Letters, 2004
- Vitamin K epoxide reductase: homology, active site and catalytic mechanismTrends in Biochemical Sciences, 2004
- Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2Nature, 2004
- Identification of the gene for vitamin K epoxide reductaseNature, 2004
- Sodium Ion Cycle in Bacterial Pathogens: Evidence from Cross-Genome ComparisonsMicrobiology and Molecular Biology Reviews, 2001
- SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modelingElectrophoresis, 1997
- Vitamin K-dependent carboxylation and vitamin K metabolism in liver. Effects of warfarin.Journal of Clinical Investigation, 1985
- Purification of a vitamin K epoxide reductase that catalyzes conversion of vitamin K 2,3-epoxide to 3-hydroxy-2-methyl-3-phytyl-2,3-dihydronaphthoquinone.Proceedings of the National Academy of Sciences, 1985
- Matrix Gla protein, a new γ-carboxyglutamic acid-containing protein which is associated with the organic matrix of boneBiochemical and Biophysical Research Communications, 1983